|
|
Grand Prix & Mediterranean Cruise: Exploring Medicine, Dentistry & the Mediterranean Healthcare Model
Barcelona to Rome on Crystal Symphony
May 24 – June 2, 2022
Experience the 79th Monaco Grand Prix! Join PES for 9 nights to explore the splendors of the Mediterranean Sea while visiting sun-drenched harbors, discovering archaeological treasures, and experiencing the thrill of the Monaco Grand Prix, while sailing aboard the all-inclusive and award-winning Crystal Symphony! Hosted by Joann & Bill Chaney!
This Seminar is planned for 12 Continuing Education Credit Hours.
CME/CE Pro... |
|
|
Challenges With Postoperative Posterior Segment Inflammation
Research indicates that sustained-release implants may have better efficacy and fewer systemic side effects when treating posterior segment uveitis than other corticosteroid delivery options or alternative nonsteroidal treatments. To provide the best treatment possible for patients undergoing eye surgery, ophthalmologists must have a thorough understanding of all available options and their benefits and challenges.
This webinar will include a lively discussion on current postoperative ther... |
|
|
Expanding the Presbyopia Practice: Growing the Population of Happy Presbyopia Patients With the Latest Technologies
Agenda:
5:30 – 6:00 pm Dinner Registration Reception
6:00 – 6:10 pm Welcome and Introduction (Eric D. Donnenfeld)
6:10 – 6:20 pm The Early Presbyope: Pharmaceutical Presbyopia Treatments (Vance Thompson)
6:20 – 6:30 pm Panel Discussion: The Pending Emergence of Refractive Lens Exchange (Eric D. Donnenfeld)
6:30 – 6:40 pm The Cataract Patient: Addressing Patient Needs with Next-Generation Presbyopia-Correcting IOLs (Karolinne M. Rocha)
6:40 – 7:00 pm Case Presentat... |
|
|
Battling the Rock-Hard Cataract: Managing Complex Cataract Extraction with the Latest Phaco Techniques and Technologies*
Agenda:
5:30 – 6:00 pm Dinner Registration Reception
6:00 – 6:05 pm Welcome and Introduction
6:05 – 6:17 pm Complex Video Cases Part 1: Phaco Techniques: Viscoelastic and Chopping
6:17 – 6:27 pm Discussion
6:27 – 6:39 pm Complex Video Cases Part 2: Phaco Dynamics: Settings, Fluidics, and Power Modulation
6:39 – 6:49 pm Discussion
6:49 – 7:01 pm Complex Video Cases Part 3: Tools for Complex Cases: Laser Cataract Surgery, Capsular Tension Rings, Pupil Expansion Devices, et... |
|
|
Neurotrophic Keratitis: Diagnosis and Testing
View this case discussion between Francis Mah, MD and John D. Sheppard, MD, MMSc, as they review the steps of a neurotrophic keratitis diagnostic exam and details of corneal sensitivity testing. Drs. Mah and Sheppard will also provide clinical pearls through a case discussion.
Learning Objectives
Upon completion of this activity, the participant should be able to:
Identify the stages of neurotrophic keratitis
Recognize how to differentiate neurotrophic keratitis from similar diseases
... |
|
|
7-Night Costa Mujeres CME AWAY Resort
Grand Palladium Costa Mujeres & TRS Coral, Costa Mujeres, Mexico
Grand Palladium Costa Mujeres Resort & Spa is located on Costa Mujeres beach, an esteemed spot on the Mexican Caribbean, just a short drive from the vibrant town of Cancún. Its 5-star sporting and leisure activities are well-suited for families, couples or groups of friends looking for a Caribbean holiday in Mexico. With Infinite Indulgence®, Everything is included. The Family Selection service, premium sports facilities, hi... |
|
|
7-Night Barbados CME AWAY® Resort - Cardiovascular Disease, Diabetes, Pain Management & General Family Medicine
Beachfront luxury takes on new meaning with rooms and suites nestled along the pristine white sands of Dover Beach. Experience the Royal Treatment at Sandals Royal Barbados, the all-new, all-suite resort in the spirited St. Lawrence Gap area. Featuring a number of Sandals firsts, including the first rooftop pool and bar, the first 4-lane bowling alley, the first men’s only barbershop, and two new restaurant concepts – American Tavern and Chi Asian. This 222 all-suite resort will also featu... |
|
|
Roundtable Discussion Part 3: Efficacy, Safety, and Comfort Considerations for Pharmaceutical Presbyopia Treatments
Drs. Richard Lindstrom, John Berdahl, Preeya Gupta, Edward Holland, Sheri Rowen, Derrell White, and Elizabeth Yeu discuss the efficacy, safety, and comfort considerations for pharmaceutical presbyopia treatments. They also discuss the new and emerging pharmaceutical presbyopia treatments, and how to guide these patients throughout their journey.
|
|
|
Roundtable Discussion Part 2: Impact of Presbyopia Progression on Quality of Life
Drs. Richard Lindstrom, John Berdahl, Preeya Gupta, Edward Holland, Sheri Rowen, Derrell White, and Elizabeth Yeu discuss the impact of presbyopia progression on a patient’s quality of life. Presbyopia is often the first sign of aging, and it can impact daily activities. They discuss best practices for identifying and diagnosing presbyopia patients.
|
|
|
Roundtable Discussion Part 1: Defining the Fundamental Etiology of Presbyopia
Drs. Richard Lindstrom, John Berdahl, Preeya Gupta, Edward Holland, Sheri Rowen, Derrell White, and Elizabeth Yeu discuss the fundamental etiology of presbyopia. They discuss the structural changes of the lens and how they correlate with functional performance. They also discuss the prevalence and demographics of today’s presbyopic patient.
|
|
|
Drs. Karpecki and Schaeffer Discuss the Pharmacological Presbyopia Treatment Consensus Statement
Drs. Paul Karpecki and Jack Schaeffer define presbyopia and discuss the impact of presbyopia on a patient’s everyday life. They discuss the incidence and prevalence of presbyopia in the general population, and the need to diagnose it earlier. They also describe efficacy, safety, and comfort considerations for emerging pharmacological presbyopia treatment options. Drs. Paul Karpecki and Jack Schaeffer discuss emerging pharmacological presbyopia treatments, including ocular surface health cons... |
|
|
Drs. Yeu and Berdahl Discuss Diagnosing and Treating Presbyopia
Drs. Elizabeth Yeu and John Berdahl define presbyopia and discuss the impact of presbyopia on a patient’s everyday life. They also discuss the incidence and prevalence of presbyopia in the general population. This is Part 2 of 2.
|
|
|
Harnessing the Suprachoroidal Space for the Treatment of Posterior Segment Eye Diseases
This satellite symposium will focus on the suprachoroidal space as a novel route of drug delivery for the treatment of retinal diseases such as uveitic macular edema, diabetic retinopathy/diabetic macular edema, and neovascular age-related macular degeneration.
Join the faculty for an insightful presentation on key trials examining the suprachoroidal space injections and proper administration techniques, followed by an engaging discussion on how these advanced therapies may alter the treatm... |
|
|
PHARMACOLOGICAL PRESBYOPIA TREATMENT CONSENSUS STATEMENT: CLINICAL RECOMMENDATIONS FOR TODAY’S PRESBYOPIA PATIENT
This supplement, captured from a delphi panel of expert key opinion leaders, provides consensus recommendations related to defining, diagnosing, and pharmacologically treating presbyopia.
This certified CME/CE activity is designed for optometrists and ophthalmologists who care for patients with presbyopia.
|
|
|
VBS Fellows Foray 2021: Case-Based Examples and Real-World Treatment Strategies - On-demand Webinar
Carefully selected cases are presented by fellows from around the globe. Retina cases you would not believe! Real-world treatment strategies will be enthusiastically discussed among the esteemed panel members. This truly unique series is designed for fellows, residents, and eye care specialists who recently entered practice and are involved in the management of patients with vitreoretinal disorders.
|
|
|
Update on Geographic Atrophy and Complement System–based Therapeutics
The impact on quality of life for patients with geographic atrophy (GA) is significant. This supplement reviews the prevalence of age-related macular degeneration (AMD), including advanced AMD (exudative and GA) as well as the pathogenesis of GA and the complex role of the complement system in GA development. The faculty members also discuss the latest clinical trial data for pipeline candidates targeting the complement pathways for the treatment of GA.
This certified CME activity is design... |
|
|
Breaking Barriers to Care: Retinal Disease in At-Risk Populations
CONTENT SOURCE
This continuing medical education (CME) activity captures content from a live virtual symposium.
ACTIVITY DESCRIPTION
This supplement focuses on timely issues related to race and socioeconomics and how they affect patient care. The faculty discuss access to care, disease awareness among patients with the highest risk factors and treatment noncompliance.
TARGET AUDIENCE
This certified CME activity is designed for ophthalmologists. |
|
|
Customizing Treatment Plans for the Diabetic Patient - On-demand
In this enduring material, Program Chair Allen C. Ho, MD, FACS, and John W. Kitchens, MD, will focus on the importance of working with diabetic patients and caregivers to create an individualized approach to treatment in an attempt to minimize loss to follow-up. Drs. Ho and Kitchens will also discuss potential solutions to patient compliance issues related to socioeconomics and other factors. |
|
|
Customizing Treatment Plans for the Diabetic Patient - On-demand
In this enduring material, Program Chair Allen C. Ho, MD, FACS, and John W. Kitchens, MD, will focus on the importance of working with diabetic patients and caregivers to create an individualized approach to treatment in an attempt to minimize loss to follow-up. Drs. Ho and Kitchens will also discuss potential solutions to patient compliance issues related to socioeconomics and other factors. |
|
|
Challenging Diabetic Cases: A Discussion on the Art and Science of Patient Management
Retina Specialists Allen C. Ho, MD, FACS, and Jayanth Sridhar, MD, discuss two patient cases that highlight some of the challenges faced with caring for patients with diabetic eye disease and the risk for loss to follow-up.
|
|
|
Illustrative Cases and Current Concepts in Diabetic Retinopathy
Allen C. Ho, MD, FACS, and Eric Nudleman MD, PhD, share their insights on best practices and strategies for a cross-disciplinary approach to diabetes management to better manage patients with diabetic retinopathy. Through complex case discussions, these leaders in retina also review ways to execute patient education plans highlighting the importance of frequent diabetic macular edema treatment to improve patient compliance. |
|
|
Wet AMD Pipeline Therapies Part 3: KSI-301 and GB-102
In this video case discussion, Program Chair Christina Y. Weng, MD, MBA, and Basil K. Williams Jr, MD, review details of a patient with wet age-related macular degeneration treated during the COVID-19 pandemic. This case highlights the need for increased durability of treatment options.
Drs. Weng and Williams also discuss the latest data on two investigational anti-VEGFs: an antibody biopolymer conjugate and a pan-VEGF plus placental growth factor inhibitor. |
|
|
Wet AMD Pipeline Therapies Part 2: PDS and RGX-314
In this video case discussion, Program Chair Christina Y. Weng, MD, MBA, and Peter A. Campochiaro, MD, review pipeline therapies for wet age-related macular degeneration. The faculty review challenging cases that would have potentially different outcomes with investigative therapies such as gene therapy and a novel, long-acting drug delivery system. |
|
|
Wet AMD: Pipeline Therapies Part 1 - Faricimab and OPT-302
In this video case discussion, Program Chair Christina Y. Weng, MD, MBA, and Diana V. Do, MD, review pipeline therapies for wet age-related macular degeneration. Drs. Do and Weng assess challenging cases and focus specifically on how specific investigative therapies that target VEGF-A, C and D may have the potential to extend treatment intervals. |
|
|
KOL Knockout™: Glaucoma Edition - Personalized Treatment Plans in Medical Glaucoma Management - Round 1
This fun and exciting virtual CME program focusing on glaucoma is a game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Douglas Rhee, MD, the first of three rounds will feature Jody Piltz-Seymour, MD, Nathan M. Radcliffe, MD, and Arsham Sheybani, MD, as contestants.
This content was captured during a live virtual symposium. Voting took place during the symposium. |
|
|
Neurotrophic Keratitis: Diagnosis, Comorbidities, Ocular Exam
View this case discussion between Francis Mah, MD, and Karolinne Maia Rocha, MD, PhD, as they review how to identify the stages of neurotrophic keratitis and share tips for differentiating neurotrophic keratitis from similar diseases. |
|
|
Neurotrophic Keratitis: Treating the Stages
View this case discussion between Francis Mah, MD, and Kenneth A. Beckman, MD, to learn about the importance of treating the stages of neurotrophic keratitis and the available therapeutic agents. |
|
|
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration
September 2021: VBS Literature Update
Khurana RN, Kunimoto D, Yoon YH, et al. Two-year results of the phase 3 randomized controlled study of abicipar in neovascular age-related macular degeneration. Ophthalmology. 2021;128(7):1027-1038. |
|
|
The Science of DED: The Role of Tear Film Homeostasis and Trigeminal Nerves
Dry eye disease (DED) is a common multifactorial disorder that perpetuates itself in a vicious circle of inflammation, tear film instability, neurosensory abnormalities, and hyperosmolarity resulting in an ongoing immune response.
This satellite symposium will highlight the latest scientific findings on DED and the novel approaches currently under investigation to treat ocular surface disease. |
|
|
Tear Film Homeostasis & Trigeminal Nerves: An In-Depth Look at the Science Behind Dry Eye
Dry eye disease (DED) is a common multifactorial disorder that perpetuates itself in a vicious circle of inflammation, tear film instability, neurosensory abnormalities, and hyperosmolarity resulting in an ongoing immune response.
This satellite symposium will highlight the latest scientific findings on DED and the novel approaches currently under investigation to treat ocular surface disease. |
|
|
On the Horizon: New Options for Treating Presbyopia
Pharmaceutical options for treatment of presbyopia will change the conversations between eye care providers and patients. These drugs are also expected to provide a gateway for more patients to visit eye care providers. The current options simply do not completely satisfy all patients.
This live event will include engaging discussions among the panel members and audience related to underlying mechanisms of presbyopic changes; pharmacological properties of newly emerging presbyopia correctin... |
|
|
https://evolvemeded.com/webinars/2151-aaopt-neurotrophic-keratitis
This satellite symposium will feature an engaging presentation on the potential causes of neurotrophic keratitis, how to differentiate it from similar diseases, and when referrals may be necessary. Treatment options will also be discussed, including the mechanisms of action of newer therapies and when they should be introduced.
This presentation will be followed by case discussions and audience question-and-answer session. |
|
|
Expert Illustrations & Commentaries™: Visualizing the Role of Nitric Oxide in Glaucoma
Target Audience
This educational activity is directed toward ophthalmologists and optometrists, including those in residency and fellowship training. Other clinicians involved in the care of patients with a diagnosis of glaucoma are also invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
• Characterize the structural and functional changes that occur in aqueous humor outflow routes in open-angle glaucoma (OAG)
• E... |
|
|
Medical Crossfire®: Expert Perspectives in Neurotrophic Keratitis – Updates in Optimal Treatment Strategies & Emphasizing Importance of Early Intervention
Target Audience
This online educational activity is directed toward ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with NK.
Activity Overview
The Medical Crossfire™, one of PER’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirted discussions and debates on a particular clinical topic. In this activity, 4 key thought leaders explore the latest data regarding c... |
|
|
Cataract Surgery: Discussions on Post-Operative Ocular Inflammation
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following c... |
|
|
MIGS: Managing Post-Operative Inflammation
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following cat... |
|
|
Cataract-Refractive Surgery: Longer Duration Therapies for Postoperative Pain and Inflammation
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following c... |
|
|
Advances in Sustained-Release Agents for Post-Vitrectomy Pain and Inflammation
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following c... |
|
|
Tools & Techniques to Enhance Surgical Efficacy & Efficiency
This series of six webcasts offers insight on various issues that are important to eye care professionals. Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and the... |
|
|
Geographic Atrophy: Insights Into Current Management and Potential Therapies
This supplement focuses on the management of patients with geographic atrophy (GA). The faculty reviews the prevalence of GA, risk factors for disease, ideal imaging modalities to diagnose and monitor its progression, and the growing pipeline of GA treatments and their mechanisms of action. |
|
|
Pharmaceutical Approaches to Presbyopia Management
Emerging pharmaceutical options for the treatment of individuals with presbyopia are poised to enter the eye care landscape. This novel approach represents a completely new paradigm for eye care providers to consider when discussing the array of options available with patients. |
|
|
Dr. Srinivasan Discusses The 2020 Global Consensus on Corneal Irregularity
In this video, Dr. Sathish Srinivasan discusses the 2020 Global Consensus on Corneal Irregularity, in which a global group of 9 experts got together to discuss and vote on best practices and guidelines for defining, diagnosing and treating irregular corneas. TARGET AUDIENCE This certified CME activity is designed for general ophthalmologists and specialists who treat irregular corneas. |
|
|
Dr. Lindstrom Discusses The 2020 Global Consensus on Corneal Irregularity
In this video, Dr. Richard L. Lindstrom discusses the 2020 Global Consensus on Corneal Irregularity, in which a global group of 9 experts got together to discuss and vote on best practices and guidelines for defining, diagnosing and treating irregular corneas. TARGET AUDIENCE This certified CME activity is designed for general ophthalmologists and specialists who treat irregular corneas. |
|
|
Dr. Al-Mohtaseb and Dr. Farid Discuss The 2020 Global Consensus on Corneal Irregularity
In this video, Dr. Zaina Al-Mohtaseb and Dr. Marjan Farid discuss the 2020 Global Consensus on Corneal Irregularity, in which a global group of 9 experts got together to discuss and vote on best practices and guidelines for defining, diagnosing and treating irregular corneas. TARGET AUDIENCE This certified CME activity is designed for general ophthalmologists and specialists who treat irregular corneas. |
|
|
Ocular Surface Disease: Etiologies and Treatment Modalities
This continuing medical education (CME/CE) activity captures content from a roundtable discussion. ACTIVITY DESCRIPTION Nearly 33% of patients in eye care clinics present with complaints about dry eye signs and symptoms. Clinicians remain challenged with both the diagnosis and best treatment options for dry eye disease (DED) because, to date, multiple causes of the disorder have been identified. This activity will help to inform clinicians on methods to improve the care of patients with DED. T... |
|
|
Mastering the Fundamentals of Presbyopia-Correcting IOLs: Minimizing Postoperative Refractive Errors and Elevating Quality of Vision by Optimizing Materials
This course is designed to educate ophthalmologists on the fundamentals of optimizing outcomes in presbyopia-correcting IOL patients. In this course, faculty will discuss how materials and other IOL parameters elevate quality of vision. Faculty will also review recommendations for minimizing postoperative refractive errors to maximize patient satisfaction. |
|
|
Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient
This course is designed to educate ophthalmologists about new and emerging pharmacological treatments for pre-cataract presbyopic patients. This course will focus on the unique psychology of the pre-cataract presbyopia patient, details on evolving treatment options, and faculty will offer pearls for identifying candidates and mastering conversations with these patients throughout their journey. |
|
|
Retina Jeopardy: 20/20 Edition
Jeopardy!® is the iconic trivia game show dating back to the 1960s. This unique and engaging educational CME activity will mimic that familiar format. Specifically, the game will feature retinal disease categories with questions per category, each with a specific value. The higher the value, the more difficult the question, but also higher the reward! This certified CME activity is designed for Senior Fellows, Junior Fellows, and Residents who diagnose and treat patients with retinal disease. |
|
|
KOL Knockout™: Cataract Edition —Maximizing the Use of Aberrometry, Femtosecond Lasers, and Advanced IOLs to Improve Postoperative Outcomes in Cataract Surgery - Final Round
This fun and exciting virtual CME program, hosted by Uday Devgan, MD, FACS, FRCS, is a game show-style quiz competition that features Round 2 champion David A. Goldman, MD, along with two new KOL contestants: John A. Hovanesian, MD, and Denise M. Visco, MD, MBA.
The program includes a brief presentation followed by patient case studies. Each KOL weighs in on treatment options, and answers questions from the audience! Will Dr. Goldman keep his winning title or will Drs. Hovanesian or Visco t... |
|
|
KOL Knockout™: Cataract Edition — Maximizing the Use of Aberrometry, Femtosecond Lasers, and Advanced IOLs to Improve Postoperative Outcomes in Cataract Surgery - Round 1
This new and exciting program, hosted by Uday Devgan, MD, FACS, FRCS, is a game show-style quiz competition that features key opinion leaders (KOLs)/contestants Zaina Al-Mohtaseb, MD; Ravi D. Goel, MD; and Robert F. Melendez, MD, MBA. This program includes a brief presentation followed by patient case studies. The panel members weigh in on treatment options and the audience determines the KOL KnockoutTM: Cataract Edition winner! There is learning, laughter, and only one KOL left standing! The ... |
|